Organon & Co. Soars 17.92% to Hit Intraday High of USD 6.96

Organon & Co. has experienced significant activity today, with the stock surging by 17.92% on April 9, 2026. The stock reached an intraday high of USD 6.96, marking a notable point in its trading session. In terms of performance metrics, Organon & Co. has shown a 1-day performance that outpaces the S&P 500, which recorded a modest gain of 0.62%. Over the past week, the stock has risen by 8.65%, again outperforming the S&P 500's 3.68% increase. However, the longer-term outlook reveals challenges, with a 1-year performance decline of 45.33%, contrasting sharply with the S&P 500's gain of 25.06%. The company's market capitalization stands at USD 1,650 million, categorizing it as a small-cap entity within the Pharmaceuticals & Biotechnology industry. Despite a low debt-to-equity ratio and a return on equity of 163.16%, the stock has faced headwinds, including a significant drop in net profit and inventory turnover. Overall, while today's performance is noteworthy, the stock's historical performance indicates a complex financial landscape for Organon & Co.